Gene · 9507
Papers2,479
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 2,479
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Galectin network in osteoarthritis: galectin-4 programs a pathogenic signature of gene and effector expression in human chondrocytes in vitro. | Histochem Cell Biol | 2022 | 34846578 | PubTator, text mining | PubMed |
| Kupffer cells regulate liver recovery through induction of chemokine receptor CXCR2 on hepatocytes after acetaminophen overdose in mice. | Arch Toxicol | 2022 | 34724096 | PubTator, text mining | PubMed |
| Synergistic upregulation of ADAMTS4 (aggrecanase-1) by cytokines and its suppression in knee osteoarthritic synovial fibroblasts. | Lab Invest | 2022 | 34718343 | PubTator, text mining | PubMed |
| The role of vascular smooth muscle cells in the development of aortic aneurysms and dissections. | Eur J Clin Invest | 2022 | 34698377 | PubTator, text mining | PubMed |
| Blood and urine biomarkers in osteoarthritis - an update on cartilage associated type II collagen and aggrecan markers. | Curr Opin Rheumatol | 2022 | 34652292 | PubTator, text mining | PubMed |
| Amitriptyline blocks innate immune responses mediated by toll-like receptor 4 and IL-1 receptor: Preclinical and clinical evidence in osteoarthritis and gout. | Br J Pharmacol | 2022 | 34643941 | PubTator, text mining | PubMed |
| Pharmacological characterization of GLPG1972/S201086, a potent and selective small-molecule inhibitor of ADAMTS5. | Osteoarthritis Cartilage | 2022 | 34626798 | PubTator, text mining | PubMed |
| Evaluating whole-genome expression differences in idiopathic and diabetic adhesive capsulitis. | J Shoulder Elbow Surg | 2022 | 34352401 | PubTator, text mining | PubMed |
| Role of HIF-2α/NF-κB pathway in mechanical stress-induced temporomandibular joint osteoarthritis. | Oral Dis | 2022 | 34342085 | PubTator, text mining | PubMed |
| Extracellular Vesicles as an Emerging Treatment Option for Intervertebral Disc Degeneration: Therapeutic Potential, Translational Pathways, and Regulatory Considerations. | Adv Healthc Mater | 2022 | 34297485 | PubTator, text mining | PubMed |
| Engineering osteoarthritic cartilage model through differentiating senescent human mesenchymal stem cells for testing disease-modifying drugs. | Sci China Life Sci | 2022 | 34109475 | PubTator, text mining | PubMed |
| Diabetes Mellitus and the Development of Lumbar Canal Stenosis: Is There Any Relevance? | Asian Spine J | 2022 | 33957024 | PubTator, text mining | PubMed |
| Resistin induces chemokine and matrix metalloproteinase production via CAP1 receptor and activation of p38-MAPK and NF-κB signalling pathways in human chondrocytes. | Clin Exp Rheumatol | 2022 | 33886462 | PubTator, text mining | PubMed |
| Diabetes Mellitus-A Risk Factor for the Development of Lumbar Disc Degeneration: A Retrospective Study of an Indian Population. | Global Spine J | 2022 | 32964735 | PubTator, text mining | PubMed |
| CCL2 induces articular chondrocyte MMP expression through ERK and p38 signaling pathways. | Osteoarthr Cartil Open | 2021 | 36475068 | PubTator, text mining | PubMed |
| Development of a highly sensitive chemiluminescence immunoassay for quantification of aggrecanase-generated ARGS aggrecan fragments in serum. | Osteoarthr Cartil Open | 2021 | 36474987 | PubTator, text mining | PubMed |
| Regulatory T cells provide chondroprotection through increased TIMP1, IL-10 and IL-4, but cannot mitigate the catabolic effects of IL-1β and IL-6 in a tri-culture model of osteoarthritis. | Osteoarthr Cartil Open | 2021 | 36474817 | PubTator, text mining | PubMed |
| Extensive downregulation of immune gene expression by microRNA-140-3p 5' isomiR in an in vitro model of osteoarthritis. | Osteoarthr Cartil Open | 2021 | 36474808 | PubTator, text mining | PubMed |
| Human amniotic membrane modulates Wnt/β-catenin and NF-κβ signaling pathways in articular chondrocytes in vitro. | Osteoarthr Cartil Open | 2021 | 36474757 | PubTator, text mining | PubMed |
| Proper animal experimental designs for preclinical research of biomaterials for intervertebral disc regeneration. | Biomater Transl | 2021 | 35836965 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9507/papers?page=32